|
Gabutti et al (present study)
|
432/29
|
Beta
|
Sex; age; weight, presence or absence of a diabetes mellitus and/or a cardiomyopathy with EF<50%; haemoglobin; creatinine; BUN; pH; ionized calcium; albumin; CRP; ferritin; PTH; epoetin and iron dose; epoetin administration route sc vs. iv; Kt/V
|
Epoetin dose and follow-up haemoglobin
|
|
Bellazzi [24]
|
10/1
|
n.s.
|
Sex; age; haemoglobin; calcium; PTH; epoetin dose and others non specified
|
Follow-up haemoglobin
|
|
Martin Guerriero et al [20]
|
110/1
|
Alpha and beta
|
Age; weight; haemoglobin; ferritin; epoetin dose; isoform and number of administrations weekly; iron dose
|
Epoetin dose
|
|
Gaweda et al [25]
|
209/1
|
n.s.
|
Haematocrit; albumin; ferritin; iron saturation; PTH; epoetin and iron dose; Kt/V
|
Follow-up haematocrit
|
|
Jacobs et al [26]
|
166/n.s.
|
n.s.
|
Haematocrit; albumin; ferritin; iron saturation; PTH; epoetin and iron dose; Kt/V
|
Follow-up haematocrit
|
